Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose dependent effects of dobutamine on blood flow in preterm and term neonates
2015-004836-36Phase 4Terminated
- Sponsor
- Department of Anaesthesiology and Intensive Care, University of Tartu
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dobutamine in Neonatal hypoperfusion and Cardiovascular Instability, sponsored by Department of Anaesthesiology and Intensive Care, University of Tartu. Primary endpoint: Pharmacokinetics of dobutamine. Started Jan 2016; status: terminated.
02
Drugs
dobutamine
03
Conditions
Neonatal hypoperfusionCardiovascular Instability
Beyond the preview
Go deeper on 2015-004836-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004836-36.